[ad_1] NEW DELHI: UK Pharmaceutical company AstraZeneca has admitted that its Covid-19 vaccine has the potential to cause to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS), as reported by The Telegraph.AstraZeneca which collaborated with the University of Oxford to create the vaccine is currently dealing with a lawsuit that claims their vaccine…
[ad_1] LONDON: British drugs group AstraZeneca on Thursday hiked its shareholder dividend citing optimism over its strong performance.AstraZeneca “intends to increase the annualised dividend” by seven percent to $3.10 per share, in a move which was “underlining the company’s confidence in its performance and cash generation”, it said in a statement ahead of its annual…
[ad_1] NEW DELHI: Drug firm AstraZeneca Pharma will exit manufacturing at its only plant in the country, based in Bangalore, as part of a ‘global strategic review’. The company with revenues of over Rs 1,000 crore, feels that it can derive more value for its shareholders by transferring core manufacturing function to a contract manufacturer,…
[ad_1] NEW DELHI: Drug firm AstraZeneca Pharma will exit manufacturing at its only plant based in Bangalore, as part of a “global strategic review’’. The company with revenues of over Rs 1000 crore, feels that it can derive more value for its shareholders by transferring core manufacturing to a contract manufacturer. As a part of…
